These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 27550352)

  • 1. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.
    Yamamoto M; Matsuyama S; Li X; Takeda M; Kawaguchi Y; Inoue JI; Matsuda Z
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6532-6539. PubMed ID: 27550352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
    Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases.
    Earnest JT; Hantak MP; Li K; McCray PB; Perlman S; Gallagher T
    PLoS Pathog; 2017 Jul; 13(7):e1006546. PubMed ID: 28759649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.
    Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S
    Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner.
    Yamamoto M; Kiso M; Sakai-Tagawa Y; Iwatsuki-Horimoto K; Imai M; Takeda M; Kinoshita N; Ohmagari N; Gohda J; Semba K; Matsuda Z; Kawaguchi Y; Kawaoka Y; Inoue JI
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca
    Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
    Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
    Shirato K; Kanou K; Kawase M; Matsuyama S
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.
    Al-Qahtani AA; Lyroni K; Aznaourova M; Tseliou M; Al-Anazi MR; Al-Ahdal MN; Alkahtani S; Sourvinos G; Tsatsanis C
    Oncotarget; 2017 Feb; 8(6):9053-9066. PubMed ID: 28118607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice.
    Li K; Wohlford-Lenane CL; Channappanavar R; Park JE; Earnest JT; Bair TB; Bates AM; Brogden KA; Flaherty HA; Gallagher T; Meyerholz DK; Perlman S; McCray PB
    Proc Natl Acad Sci U S A; 2017 Apr; 114(15):E3119-E3128. PubMed ID: 28348219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism.
    Park JE; Li K; Barlan A; Fehr AR; Perlman S; McCray PB; Gallagher T
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12262-12267. PubMed ID: 27791014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells.
    Kato T; Takami Y; Kumar Deo V; Park EY
    J Biotechnol; 2019 Dec; 306():177-184. PubMed ID: 31614169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein.
    Li W; Hulswit RJG; Widjaja I; Raj VS; McBride R; Peng W; Widagdo W; Tortorici MA; van Dieren B; Lang Y; van Lent JWM; Paulson JC; de Haan CAM; de Groot RJ; van Kuppeveld FJM; Haagmans BL; Bosch BJ
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8508-E8517. PubMed ID: 28923942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak.
    Kim Y; Cheon S; Min CK; Sohn KM; Kang YJ; Cha YJ; Kang JI; Han SK; Ha NY; Kim G; Aigerim A; Shin HM; Choi MS; Kim S; Cho HS; Kim YS; Cho NH
    mBio; 2016 Mar; 7(2):e00019. PubMed ID: 26933050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
    Sun Y; Zhang H; Shi J; Zhang Z; Gong R
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating MERS-CoV Entry Pathways.
    Qing E; Hantak MP; Galpalli GG; Gallagher T
    Methods Mol Biol; 2020; 2099():9-20. PubMed ID: 31883084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors.
    Sisk JM; Frieman MB; Machamer CE
    J Gen Virol; 2018 May; 99(5):619-630. PubMed ID: 29557770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of peptidic MERS-CoV entry inhibitors].
    Xia S; Wang Q; Liu SW; Lu L; Jiang SB
    Yao Xue Xue Bao; 2015 Dec; 50(12):1513-9. PubMed ID: 27169270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.